138 related articles for article (PubMed ID: 37665127)
1. Intralesional 5-fluorouracil as a management for cutaneous squamous cell carcinomas: A rural Australian retrospective case series.
Luu W; McRae MY
Australas J Dermatol; 2023 Nov; 64(4):556-559. PubMed ID: 37665127
[TBL] [Abstract][Full Text] [Related]
2. Dilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series.
Marka A; Rodgers D; Zelaya Castillo L; Hoyt B; Chapman M; Carter J
J Drugs Dermatol; 2023 May; 22(5):507-508. PubMed ID: 37133471
[TBL] [Abstract][Full Text] [Related]
3. Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
Que SKT; Compton LA; Schmults CD
J Am Acad Dermatol; 2019 Jul; 81(1):111-122. PubMed ID: 31103317
[TBL] [Abstract][Full Text] [Related]
4. A patient with squamous cell carcinoma
Vazquez T; Florez-White M
J Dermatolog Treat; 2020 Mar; 31(2):180-182. PubMed ID: 30843746
[No Abstract] [Full Text] [Related]
5. Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squamous cell carcinoma and keratoacanthoma: A retrospective analysis.
Hamad J; Jolly PS
Dermatol Ther; 2021 Nov; 34(6):e15139. PubMed ID: 34549487
[TBL] [Abstract][Full Text] [Related]
6. Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil.
Morse LG; Kendrick C; Hooper D; Ward H; Parry E
Dermatol Surg; 2003 Nov; 29(11):1150-3; discussion 1153. PubMed ID: 14641346
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
8. Intralesional 5-Fluorouracil in the Treatment of Lower Leg Squamous Cell Carcinoma.
Mackey M; Shahsavari A; Mackey VT
J Drugs Dermatol; 2018 Nov; 17(11):1241-1243. PubMed ID: 30500149
[TBL] [Abstract][Full Text] [Related]
9. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Maghfour J; Kuraitis D; Murina A
J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma.
Kraus S; Miller BH; Swinehart JM; Shavin JS; Georgouras KE; Jenner DA; Griffin E; Korey A; Orenberg EK
J Am Acad Dermatol; 1998 Mar; 38(3):438-42. PubMed ID: 9520026
[TBL] [Abstract][Full Text] [Related]
11. Intralesional 5-Fluorouracil for the Nonsurgical Management of Low-Risk, Invasive Squamous Cell Carcinoma.
Dando EE; Lim GFS; Lim SJM; Kim C; Pugliano-Mauro M
Dermatol Surg; 2020 Jan; 46(1):126-130. PubMed ID: 30608299
[No Abstract] [Full Text] [Related]
12. Interventions for cutaneous Bowen's disease.
Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
[TBL] [Abstract][Full Text] [Related]
13. Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged.
Cartei G; Cartei F; Interlandi G; Meneghini G; Jop A; Zingone G; Tabaro G; Mazzoleni F
Am J Clin Oncol; 2000 Apr; 23(2):181-4. PubMed ID: 10776981
[TBL] [Abstract][Full Text] [Related]
14. Poorly differentiated cutaneous squamous cell carcinomas have high incomplete excision rates with UK minimum recommended pre-determined surgical margins.
Kiely J; Kostusiak M; Bloom O; Roshan A
J Plast Reconstr Aesthet Surg; 2020 Jan; 73(1):43-52. PubMed ID: 31473117
[TBL] [Abstract][Full Text] [Related]
15. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.
Kirby JS; Miller CJ
J Am Acad Dermatol; 2010 Oct; 63(4):689-702. PubMed ID: 20605654
[TBL] [Abstract][Full Text] [Related]
16. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
Couch SM; Custer PL
Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
[TBL] [Abstract][Full Text] [Related]
17. Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.
Miller BH; Shavin JS; Cognetta A; Taylor RJ; Salasche S; Korey A; Orenberg EK
J Am Acad Dermatol; 1997 Jan; 36(1):72-7. PubMed ID: 8996264
[TBL] [Abstract][Full Text] [Related]
18. Artificial neural networks allow response prediction in squamous cell carcinoma of the scalp treated with radiotherapy.
Damiani G; Grossi E; Berti E; Conic RRZ; Radhakrishna U; Pacifico A; Bragazzi NL; Piccinno R; Linder D
J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1369-1373. PubMed ID: 31968143
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU).
Kurtis B; Rosen T
J Dermatol Surg Oncol; 1980 Feb; 6(2):122-7. PubMed ID: 7354186
[TBL] [Abstract][Full Text] [Related]
20. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil.
Midena E; Angeli CD; Valenti M; de Belvis V; Boccato P
Br J Ophthalmol; 2000 Mar; 84(3):268-72. PubMed ID: 10684836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
